
PMO wants drug pricing, pharma to move to health from chemical ministry
New Delhi: India’s drug pricing regulator to be moved to health ministry
The PMO plans to transfer India’s apex drug pricing regulator from the ministry of chemicals and fertilizers to the health ministry because it has the technical expertise needed to take decisions on drug pricing.
Discussions in the PMO have begun to move the National Pharmaceutical Pricing Authority (NPPA) and department of pharmaceuticals to the health ministry.
This is a part of rationalizing drug safety and pricing as the Drug Controller General of India -- responsible for approving trials, licensing, drug safety, manufacturing standards, and sale, import and distribution of drugs --.is art of the health ministry.
While officials in the health ministry refused to confirm anything officially, a source, on condition of anonymity, said, “They do not possess the technical knowledge required for the job. There also have been some controversial decisions lately.”
The immediate trigger could have been the controversy surrounding fixing the cardiac stent pricing under National List of Essential Medicines (NLEM). There was criticism over stents having been divided just into two categories when there are several categories available, especially under the drug eluting stents category.
Confirming the development, a source in the health ministry said, “Yes. It is true. The PMO is thinking about the transfer and this is a step in the right direction.”
The health ministry had for long wanted to be given charge of these two drug regulatory bodies. There were even talks of dissolving NPPA in the past because of the too much control it wielded in deciding drug prices.
“You obviously can’t have two price categories when there are several varieties available in market. It required more thought but clearly there wasn’t enough technical expertise,” said the source.

Centre differs with SC on additional courts for cheque bounce cases
- Unhappy with the response, the bench headed by Chief Justice of India (CJI) SA Bobde asked Solicitor General Tushar Mehta to appear in the case along with Additional Solicitor General (ASG) Vikramjeet Banerjee, who presented the note to the Court.

Man in Maharashtra wanted to ride horse to office to overcome spinal problem
- The officer withdrew his request after an orthopaedic surgeon said his purpose would not be served by buying a horse.

India signs pact with Philippines for supply of BrahMos missile

Why EC opted for 8-phase polls in Bengal

Only Centre can enforce new digital media rules: I&B ministry to states

Govt allows 24x7 vaccination as surge continues in six states

Covid-19: Canada receives 500,000 doses of Covidshield vaccine made in India
_1614794080348_1614794098844.jpg)
Odisha govt deploys 1000 men to contain huge blaze in Similipal National Park
- Similipal, among the few included by the UNESCO in its list of critical biosphere reserves of the world, covers an area of 5569 sq km and contributes 38% of the total protected area network in Odisha. It is also one of the oldest tiger reserves in the country.

Odisha warns people against fake co-morbidity certificates for Covid-19 vaccine
- The Union health ministry last week had specified 20 comorbidities among people aged between 45 and 59 years who will get the vaccine.

Infosys, Accenture to cover Covid-19 vaccination costs for Indian employees

Haryana clears 75% quota for local candidates in private sector
- Haryana's new law provides reservation for local people in private sector jobs with a monthly salary of less than ₹50,000 for 10 years

Railway Minister Piyush Goyal flags off Siddhabali Jan Shatabdi Special Train

'Reckless': Naga group on governor RN Ravi's peace talks concluded statement

Security forces bust Hizbul Mujahideen hideout in Awantipora forest
